Podium Presentations S15 lesser magnitude: a decline of 51% in 6-month-old compared to 3-monthold mice. In the DMM model OA developed on the medial tibia where the number of Ihh expressing cells decreased 68% compared to sham operated individuals. The lateral tibial cartilage did not display a significant change in Ihh expression. In collagenase induced OA, Ihh expression decreased 18% on day 14, 42% on day 21 and 72% on day 42 in medial tibial cartilage compared to controls. On the lateral side this was 37%, 51% and 55% respectively. In spontaneous OA (STR/ort), demonstrating mainly OA development at the medial tibia, a drastic change in Ihh expression was found with age and accordingly with OA in this age-related OA model. Whereas there is still normal Ihh expression at 8 weeks of age, it was almost absent by the age of 6 months in medial tibial cartilage and was reduced 54% in lateral tibial cartilage. Conclusions: In the growth plate Ihh is known to keep chondrocytes in a pre-hypertrophic state by blocking further (terminal) differentiation. We found that with age there is a decrease in Ihh expression which is already found at an age of 6 months in C57Bl/6 mice. In earlier studies we showed that in normal articular chondrocytes there is high expression of TGF-beta signaling via the ALK5 receptor, leading to Smad2 phosphorylation. This pathway is known to block terminal differentiation in chondrocytes. During ageing and OA, this suppressive pathway of terminal differentiation is reduced. In addition, we previously found that the balance between the ALK5 pathway and the alternative TGF-beta pathway via ALK1 leading to Smad1/5/8 phosphorylation is tilted during OA favoring the ALK1-side. This Smad1/5/8 pathway is a known stimulator of chondrocyte hypertrophy. Thus with age and OA we found a reduction in the block on terminal differentiation and even a shift towards stimulation of terminal differentiation. The results of this study, loss of Ihh expression during ageing and OA, appear to conform the hypothesis that chondrocytes undergo a shift in phenotype during ageing and OA that make these cells prone to terminal differentiation-like alterations and ageing cartilage to OA development.
lesser magnitude: a decline of 51% in 6-month-old compared to 3-monthold mice. In the DMM model OA developed on the medial tibia where the number of Ihh expressing cells decreased 68% compared to sham operated individuals. The lateral tibial cartilage did not display a significant change in Ihh expression. In collagenase induced OA, Ihh expression decreased 18% on day 14, 42% on day 21 and 72% on day 42 in medial tibial cartilage compared to controls. On the lateral side this was 37%, 51% and 55% respectively. In spontaneous OA (STR/ort), demonstrating mainly OA development at the medial tibia, a drastic change in Ihh expression was found with age and accordingly with OA in this age-related OA model. Whereas there is still normal Ihh expression at 8 weeks of age, it was almost absent by the age of 6 months in medial tibial cartilage and was reduced 54% in lateral tibial cartilage. Conclusions: In the growth plate Ihh is known to keep chondrocytes in a pre-hypertrophic state by blocking further (terminal) differentiation. We found that with age there is a decrease in Ihh expression which is already found at an age of 6 months in C57Bl/6 mice. In earlier studies we showed that in normal articular chondrocytes there is high expression of TGF-beta signaling via the ALK5 receptor, leading to Smad2 phosphorylation. This pathway is known to block terminal differentiation in chondrocytes. During ageing and OA, this suppressive pathway of terminal differentiation is reduced. In addition, we previously found that the balance between the ALK5 pathway and the alternative TGF-beta pathway via ALK1 leading to Smad1/5/8 phosphorylation is tilted during OA favoring the ALK1-side. This Smad1/5/8 pathway is a known stimulator of chondrocyte hypertrophy. Thus with age and OA we found a reduction in the block on terminal differentiation and even a shift towards stimulation of terminal differentiation. The results of this study, loss of Ihh expression during ageing and OA, appear to conform the hypothesis that chondrocytes undergo a shift in phenotype during ageing and OA that make these cells prone to terminal differentiation-like alterations and ageing cartilage to OA development. Purpose: Transient receptor potential channel vanilloid 4 (TRPV4) is a calcium permeable cation channel that is gated by a number of factors, including osmolarity and temperature. Chondrocytes, the cells in articular cartilage, have been shown to perceive and respond to their osmotic and mechanical environments; however, the molecular basis of this signal transduction is not fully understood. The purpose of this study was to demonstrate the presence and functionality of TRPV4 in porcine articular cartilage. Methods: TRPV4 protein expression was examined in porcine chondrocytes via Western blotting and immunostaining. TRPV4 mRNA was measured using RT-PCR. Calcium signaling in response to osmotic stress, TRPV4 agonist/antagonist, and various calcium signaling modifying agents was measured via fluorescent imaging of calcium-sensitive dyes. Cell volume change in response to osmotic stress, TRPV4 agonist/antangonist, and the inflammatory cytokine, Il-1, were measured from light microscopy images. Changes in prostaglandin E2 (PGE2), which is a downstream effect of increased internal calcium and Il-1, levels in response to osmotic stress and TRPV4 agonist/antagonist were measured with an immunoassay. Results: TRPV4 was detected in porcine chondrocytes at the protein level and mRNA level. Addition of 4a-PDD, a TRPV4 agonist, caused calcium signaling, which was significantly blocked by the addition of ruthenium red (RR), a TRPV4 antagonist ( Fig. 1) . Calcium signaling was also inhibited by removal of extracellular calcium or blocking release from intracellular stores. Blocking TRPV4 with RR significantly modified the porcine cellular response to hypo-osmotic stress by decreasing the percentage of cells responding with a calcium signal. Addition of RR also significantly inhibited the volume recovery in response to hypo-osmotic stress, and 4a-PDD alone caused a slight volume increase (Fig. 2) . TRPV4 activation was able to prevent the inflammatory cytokine Il-1 from inhibiting this volume regulation after exposure to hypo-osmotic medium (Fig. 2) . Hypo-osmotic conditions caused PGE2 release which was blocked by the addition of RR ( Fig. 3 ).
Fig. 1:
Percentage of cells responding to stimuli with increases in intracellular calcium. Asterisks denote experimental groups that are significantly different from control within a given osmolarity (chi-squared test, p < 0.05); number signs specify bars within the 380 mOsm group that are significantly different from 380+4a-PDDm (chi-squared test, p < 0.05). Both the 280 and 480 mOsm controls are significantly different from the 380 mOsm control (chi-squared, p < 0.05). 
Conclusions:
We have shown that TRPV4 is present in articular chondrocytes and that chondrocyte response to hypo-osmotic stress is me-diated by calcium influx via the TRPV4 channel, which involves both an influx of extracellular calcium and a release of intracellular calcium stores. In addition, TRPV4 may be involved in modulating the production or influence of pro-inflammatory molecules such as PGE2 or Il-1 in hypoosmotic conditions. Because of the unique structure of cartilage, mechanical loading is directly coupled to interstitial osmolarity. Thus, in acting as an osmosensor, TRPV4 may also be acting as a mechanosensor. In addition to the short-term changes in osmolarity with loading, osmolarity of cartilage tissue may also change chronically with arthritis. Purpose: Prostaglandins (PGs) are phospholipid-derived, hormone-like molecules that serve as homeostatic bioregulators and immune and inflammatory modulators. The rate-limiting enzyme in inducible PG biosynthesis is cyclooxygenase-2 (COX-2). Prostaglandin E2 (PGE2), the major COX-2 catalytic product, serves as a feedback regulator of COX-2 (and other pro-and anti-inflammatory) gene expression. Exogenous PGE2 increases primary human synovial fibroblast (HSF) COX-2 mRNA stability and translation; these effects are dependent on p38 MAPKresponsive cis-acting adenylate/uridylate-rich elements (AREs) in the COX-2 3 -untranslated region (3 UTR). This study's purpose is to characterize the molecular factors (i.e., ARE binding proteins, AUBPs) and mechanisms by which PGE2 increases COX-2 mRNA stability and translation in HSFs. Methods: Gene reporter studies were conducted to screen three AUBPs expressed endogenously in HSFs and shown to bind the COX-2 3 UTR (i.e., AUF-1, HuR, Tristetraprolin (TTP)) for their effect on COX-2 mRNA stability/translation. HSFs were cotransfected with a luciferase (Luc)-COX-2 3 UTR reporter construct and one of three expression plasmids coding for a different AUBP. Luc activity was then quantified by luminometry as a measure of both mRNA stability and translation; results were expressed relative to Luc activity in cells transfected with an empty AUBP vector (i.e., control). AUBP mRNA and protein expression was analyzed by Northern blotting (NB) and Western blotting (WB), respectively. Subcellular localization studies were performed using real-time confocal microscopy of TTP-GFP-transfected HeLa cells; results were confirmed biochemically by WB. Results: TTP had the most marked and unambiguous effect on Luc-COX-2 3 UTR reporter activity in HSFs (55±15% decrease in Luc activity). HSF TTP mRNA levels were rapidly (20 min) and potently (3.5-fold vs. control) induced by Il-1b, but displayed a short half-life (1−2 h). Neither Il-1b-induced TTP transcription nor TTP mRNA decay was mediated by PGE2. Interestingly, three TTP transcripts of 6.0, 4.0 and 2.2 kb were detected by NB, suggesting the possible existence of additional TTP isoforms and/or splice variants. In support of this possibility, WB analysis of HSF TTP revealed the presence of a second TTP immunoreactive protein (TTP2,~60 kDa). Exogenous PGE2 almost completely abolished Il-1b-induced TTP2 protein levels after 17 h of stimulation while minimally reducing the levels of the known TTP protein (TTP1). To verify if TTP2 is a TTP isoform or splice variant, NB analysis of TTP mRNA was conducted using nuclear and cytosolic RNA extracts; only the 2.2 kb TTP transcript was detected in the cytosol, thus indicating that TTP2 is a post-translationally modified form of TTP1. Analysis of TTP's subcellular localization in HSFs and HeLa cells revealed a predominantly (95%) cytosolic localization. PGE2 promoted TTP's nuclear export within 5 min; WB analysis revealed that TTP2 is the shuttling species. The presence of TTP2 in the nucleus and the fact that it is a zinc-finger protein led us to assess its capacity to influence COX-2 gene transcription. Gene reporter studies revealed that overexpression of TTP could transactivate the COX-2 promoter by~2-fold. Conclusions: TTP2 is a novel, uncharacterized post-translational variant of TTP1. Although the exact molecular composition and function of TTP2 are unknown, it appears that TTP2 exhibits distinct nuclear (i.e., transcription) and cytosolic (i.e., mRNA decay/translation) functions with regards to COX-2 expression. PGE2's influence on TTP2's expression and subcellular distribution make it a strong candidate effector of PGE2mediated transcriptional and post-transcriptional/translational gene regulation. Medicine, Chapel Hill, NC, USA, 2 StatWorks, Inc, RTP, NC, USA, 3 University of North Carolina Department of Biostatistics, Chapel Hill, NC, USA, 4 Centers for Disease Control and Prevention, Atlanta, GA, USA Purpose: Racial differences in OA prevalence have been demonstrated at individual joint sites, but whether there are racial differences in patterns of multi-joint OA involvement is unknown. The current study was designed to assess differences in multi-joint rOA phenotypes among AA and White individuals. Methods: We conducted a cross-sectional analysis using data from the Johnston County Osteoarthritis Project (n = 1600, 67% women, 32% AA). Hand rOA was defined as (1) Kellgren-Lawrence (KL) grade 2 in at least 3 joints, including DIPs, PIPs, or CMC1; (2) at least 2 involved joints in the same joint group; (3) at least one involved DIP in digits 2−5; and (4) bilateral distribution. Tibiofemoral (TFJ) or hip joint rOA was defined as a K/L grade 2; patellofemoral rOA (PFJ) as an osteophyte grade 2; and lumbosacral spine rOA as an osteophyte grade 1 and disc space narrowing at the same vertebral level. Frequencies were calculated for all joint sites. Generalized estimating equations (GEE) were used to investigate racial differences in OA phenotypes simultaneously, adjusting for correlation among joints of the same individual. Logistic regression was used to assess multi-joint rOA phenotypes as separate outcomes (i.e. hand/knee, hand/hip) in a subset of individuals with complete data for rOA at the hand, TFJ, PFJ, hip, and knee (n = 834), with exact methods used for outcomes with small cell sizes. Analyses were also adjusted for age, gender, and BMI. Results: The mean (SD) age of the sample was 63 (11) years. Overall, 27% of the participants had hand rOA, 33% had TFJ rOA, 49% had PFJ rOA, 30% had hip rOA, and 49% had rOA of the lumbosacral spine. In unadjusted analyses by race, Whites more frequently had any hand rOA (35% vs 11%, p < 0.0001) and rOA of the spine (52% vs 44%, p = 0.03); AAs more frequently had TFJ rOA (39% vs 30%, p = 0.0003); and no racial differences were seen for hip or PFJ rOA. Results were similar in adjusted analyses by race (using GEE) except that there was no racial association for spine involvement. In unadjusted analyses of multi-joint rOA phenotypes, compared to those with no rOA at any site (15% of the subset), AAs had significantly decreased frequencies of isolated hand or PFJ involvement compared to Whites, as well as less frequent combinations of joints including the hands (hand/TFJ, hand/hip, hand/TFJ/hip, Table) . After adjustment, AAs were less likely to have any combination of involved joints that included the hands (hand only, hand/TFJ, hand/hip, or hand/TFJ/hip) compared to Whites. AAs had 50% increased odds of TFJ and hip involvement together, but this did not reach statistical significance (Table) . 
Multi-joint rOA phenotypes differ by race, with AAs more likely than Whites to have multiple large joint OA involvement. Definitions of generalized OA which emphasize hand involvement, commonly used in Whites, may not identify AA individuals with multi-joint OA.
